Navifus Corporation
Clinical trials sponsored by Navifus Corporation, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Sound waves could boost brain cancer drug delivery Results expected Dec 2026 (estimated)
- Sound waves against seizures: new device tested for Drug-Resistant epilepsy Results expected Dec 2026 (estimated)
- Sound waves aimed at the brain could tame seizures Results expected Jun 2027 (estimated)
-
Sound waves against seizures: new device tested for Drug-Resistant epilepsy
Disease control Recruiting nowThis pilot study tests a device called NaviFUS that uses low-intensity focused ultrasound to calm overactive brain areas. It involves 16 adults with drug-resistant epilepsy who still have frequent seizures despite trying at least three medications. The goal is to see if the treat…
Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Sound waves could boost brain cancer drug delivery
Disease control Recruiting nowThis Phase 3 trial tests whether combining the drug Avastin with a focused ultrasound system (NaviFUS) can improve outcomes for people with recurrent glioblastoma, an aggressive brain cancer. The ultrasound temporarily opens the blood-brain barrier to let more drug reach the tumo…
Phase 3 • Sponsor: NaviFUS Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Sound waves aimed at the brain could tame seizures
Symptom relief Recruiting nowThis early study tests a device that uses low-intensity focused ultrasound to calm overactive brain areas in people with drug-resistant temporal lobe epilepsy. Eight adults will receive up to three 10-minute ultrasound sessions. Researchers will track side effects and check if se…
Phase 1/2 • Sponsor: NaviFUS Corporation • Aim: Symptom relief
Last updated Sep 17, 2026 00:00 UTC